<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies suggest a neuroprotective function of the <z:chebi fb="0" ids="15551">PGE2</z:chebi> EP2 receptor in excitotoxic neuronal injury </plain></SENT>
<SENT sid="1" pm="."><plain>The function of the EP2 receptor was examined at time points after excitotoxicity in an organotypic hippocampal model of <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) challenge and in a permanent model of focal forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Activation of EP2 led to significant neuroprotection in hippocampal slices up to 3 hours after a toxic <z:chebi fb="0" ids="31882">NMDA</z:chebi> stimulus </plain></SENT>
<SENT sid="3" pm="."><plain>Genetic deletion of EP2 resulted in a marked increase in <z:hpo ids='HP_0001297'>stroke</z:hpo> volume in the permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="4" pm="."><plain>These findings support further investigation into therapeutic strategies targeting the EP2 receptor in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>